11491421

Source:http://linkedlifedata.com/resource/pubmed/id/11491421

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001675, umls-concept:C0036043, umls-concept:C0205195, umls-concept:C0220825, umls-concept:C0439801, umls-concept:C0441655, umls-concept:C0596545, umls-concept:C0663655, umls-concept:C0754188, umls-concept:C2603343
pubmed:issue	2
pubmed:dateCreated	2001-8-8
pubmed:abstractText	To evaluate the antiretroviral activity and safety of multiple escalating doses of amprenavir administered alone, and in combination with abacavir in HIV-1-infected adults.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9815705
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/Carbamates, http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides, http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/abacavir, http://linkedlifedata.com/resource/pubmed/chemical/amprenavir
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1359-6535
pubmed:author	pubmed-author:AntunesFF, pubmed-author:BlakeDD, pubmed-author:ClumeckNN, pubmed-author:DannerS ASA, pubmed-author:HaubrichRR, pubmed-author:MillardJJ, pubmed-author:MustafaNN, pubmed-author:MyersR ERE, pubmed-author:NacciPP, pubmed-author:SchooleyR TRT, pubmed-author:SereniDD, pubmed-author:ThompsonMM, pubmed-author:TisdaleMM, pubmed-author:van Der EndeM EME
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	89-96
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11491421-Administration, Oral, pubmed-meshheading:11491421-Adult, pubmed-meshheading:11491421-Anti-HIV Agents, pubmed-meshheading:11491421-Carbamates, pubmed-meshheading:11491421-Dideoxynucleosides, pubmed-meshheading:11491421-Dose-Response Relationship, Drug, pubmed-meshheading:11491421-Drug Therapy, Combination, pubmed-meshheading:11491421-Female, pubmed-meshheading:11491421-Genotype, pubmed-meshheading:11491421-HIV Infections, pubmed-meshheading:11491421-HIV Protease Inhibitors, pubmed-meshheading:11491421-HIV-1, pubmed-meshheading:11491421-Humans, pubmed-meshheading:11491421-Male, pubmed-meshheading:11491421-Maximum Tolerated Dose, pubmed-meshheading:11491421-Phenotype, pubmed-meshheading:11491421-Sulfonamides, pubmed-meshheading:11491421-Time Factors, pubmed-meshheading:11491421-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.
pubmed:affiliation	Division of Infectious Diseases, Health Sciences Center, University of Colorado, Denver, USA. robert.schooley@uchsc.edu
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Clinical Trial, Phase I